CR oxybutynin cost effective for OAB in France, Austria and the UK

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1443, 2004-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CR oxybutynin cost effective for OAB in France, Austria and the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 455, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria

By Guest J.F. Abegunde D. Ruiz F.J.

Clinical Drug Investigation, Vol. 24, Iss. 6, 2004-01 ,pp. : 305-321

Adis International

Access to resources Recommend Favorite

Tocilizumab cost effective in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 607, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Transdermal oxybutynin improves QOL in men with OAB

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 548, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Oxybutynin patch covers all aspects of OAB

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite